March 26, 2025

Stem Cell Transplant May Not Be Necessary in First Remission for Patients With Mantle Cell Lymphoma and Undetectable MRD

Autologous stem cell transplantation (ASCT) does not improve survival outcomes for patients with mantle cell lymphoma who achieve a deep first complete remission with undetectable measurable residual ...

The ASCO Post

March 24, 2025

Bringing Palliative Care to Every Patient With Cancer

Janet L. Abrahm, MD, FACP, FAAHPM, FASCO, has spent more than half of her oncology career as a palliative care physician. After receiving her medical degree from the University of California, San Fran...

The ASCO Post

March 24, 2025

Monica M. Bertagnolli, MD, FACS, FASCO, Joins Friends of Cancer Research Board of Directors

Friends of Cancer Research (Friends) is honored to announce the addition of former Director of the National Institutes of Health (NIH) Monica M. Bertagnolli, MD, FACS, FASCO, to its Board of Directors...

The ASCO Post

March 24, 2025

Two Decades of Collaboration: The Accelerating Anticancer Agent Development and Validation (AAADV) Workshop

Over the past 20 years, the investment in research and development of cancer therapies has been unprecedented, and the pace of new drug development has been accelerating. To illustrate this trajectory...

The ASCO Post

March 05, 2024

NCCN Updates Treatment Recommendations for Breast, Colorectal, Lung, and Other Cancers

The National Comprehensive Cancer Network® (NCCN®) is announcing several new updates to the cancer treatment practices listed in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).

The ASCO Post

September 14, 2023

Head and Neck Cancers 2022–2023 Almanac

Advances in head and neck cancer management, including optimization, de-escalation, and intensification of treatments, as well as novel immunotherapy-based regimens, signify progress in personalized therapeutic approaches.

The ASCO Post

July 17, 2023

Providing Care During Cancer Drug Shortages

Drug shortages have become a global phenomenon, reaching an all-time high and affecting nearly every therapeutic area of medicine. Even short-term drug shortages cause deleterious effects in critical ...

JADPRO

July 19, 2024

Interaction of the Gut Microbiome With Cancer Treatment

Research finds that the gut microbiome has a significant impact on cancer pathogenesis and treatment responses, opening new avenues for improving cancer therapy outcomes.

JADPRO

November 27, 2023

Expert Point of View: Helena Linardou, MD, PhD

Dr. Linardou presents promising findings on TROP-2-targeting agents for lung cancer at the 2023 World Conference on Lung Cancer, highlighting the potential to replace chemotherapy in first-line combinations.

The ASCO Post